Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.67M Buy
7,386
+41
+0.6% +$14K 1.09% 15
2026
Q1
$2.58M Buy
7,345
+46
+0.6% +$16.4K 1.31% 17
2025
Q4
$2.39M Buy
7,299
+5,452
+295% +$1.73M 1.24% 13
2025
Q3
$521K Buy
1,847
+1,452
+368% +$421K 0.2% 97
2025
Q2
$110K Sell
395
-7,450
-95% -$2.11M 0.06% 249
2025
Q1
$2.44M Buy
7,845
+6,882
+715% +$2.03M 1% 18
2024
Q4
$275K Buy
+963
New +$286K 0.13% 155

Other funds holding AMGN

AmeriFlex Group's AMGN Position: Q2 2026 in Review

AmeriFlex Group increased its Amgen (AMGN) stake by 0.56% in Q2 2026, buying an estimated $14K and bringing the position to 7,386 shares worth $2.67M. The position accounts for 1.09% of the portfolio, ranked #15.

AmeriFlex Group first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • AmeriFlex Group held 7,386 shares of Amgen worth $2.67M as of Q2 2026.
  • AmeriFlex Group bought 41 Amgen shares in Q2 2026, an estimated $14K.
  • Amgen made up 1.09% of AmeriFlex Group's portfolio in Q2 2026, its #15 holding.
  • AmeriFlex Group first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.